Sanofi gets rights to Tamiflu in the US market
The French group Sanofi has signed an agreement with Roche on the transfer of rights to the antiviral drug Tamiflu (oseltamivir) in the United States. Sanofi will receive exclusive rights to Tamiflu over-the-counter in the United States. This drug is intended for the prevention and treatment of influenza. Alan Main, executive vice president of consumer…